Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103478572 | 10347857 | 2 | F | 2012 | 20160727 | 20140729 | 20160729 | EXP | US-PFIZER INC-2014209751 | PFIZER | 44.00 | YR | F | Y | 58.96000 | KG | 20160729 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103478572 | 10347857 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 150 MG IN THE MORNING AND 300 MG IN NIGHT) | 21446 | CAPSULE, HARD | BID | ||||||||
| 103478572 | 10347857 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 225 MG, 2X/DAY | 21446 | 225 | MG | CAPSULE, HARD | BID | ||||||
| 103478572 | 10347857 | 3 | C | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | Oral | 10 MG, AS NEEDED [TAKE 1 TABLET, THREE TIMES DAILY ] | 0 | 10 | MG | TABLET | |||||||
| 103478572 | 10347857 | 4 | C | PEPCID | FAMOTIDINE | 1 | Oral | 20 MG, 2X/DAY | 0 | 20 | MG | TABLET | BID | ||||||
| 103478572 | 10347857 | 5 | C | NAMENDA | MEMANTINE HYDROCHLORIDE | 1 | Oral | 5 MG, DAILY | 0 | 5 | MG | TABLET | |||||||
| 103478572 | 10347857 | 6 | C | NAMENDA | MEMANTINE HYDROCHLORIDE | 1 | MAY INCREASE TO 1 TABLET TWICE DAILY IN 1 WEEK | 0 | 5 | MG | TABLET | BID | |||||||
| 103478572 | 10347857 | 7 | C | ULTRAM | TRAMADOL HYDROCHLORIDE | 1 | Oral | 50 MG, 2X/DAY | 0 | 50 | MG | TABLET | BID | ||||||
| 103478572 | 10347857 | 8 | C | TEMOVATE | CLOBETASOL PROPIONATE | 1 | Topical | 0.05 % 15 G TWICE DAILY | 0 | .05 | PCT | BID | |||||||
| 103478572 | 10347857 | 9 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, 2X/DAY | 0 | 40 | MG | PROLONGED-RELEASE CAPSULE | BID | ||||||
| 103478572 | 10347857 | 10 | C | CINNAMON. | CINNAMON | 1 | Oral | 500 MG, 1X/DAY | 0 | 500 | MG | CAPSULE | QD | ||||||
| 103478572 | 10347857 | 11 | C | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | Oral | 30 MG, 1X/DAY [EVERY MORNING] | 0 | 30 | MG | QD | |||||||
| 103478572 | 10347857 | 12 | C | MAXALT-MLT | RIZATRIPTAN BENZOATE | 1 | Oral | 10 MG, AS NEEDED (DISSOLVE ONE TABLET BY MOUTH ONCE AS NEEDED FOR MIGRAINE, MAY REPEAT IN 2 HOURS) | 0 | 10 | MG | TABLET | |||||||
| 103478572 | 10347857 | 13 | C | MELATONIN | MELATONIN | 1 | Oral | 10.5 MG, 1X/DAY | 0 | 10.5 | MG | TABLET | QD | ||||||
| 103478572 | 10347857 | 14 | C | COCONUT OIL | COCONUT OIL | 1 | Oral | 1000 MG, 2X/DAY | 0 | 1000 | MG | BID | |||||||
| 103478572 | 10347857 | 15 | C | OMEGA 3 /01333901/ | FISH OILTOCOPHEROL | 1 | Oral | 645 MG, 1X/DAY [NIGHTLY AT BED TIME] | 0 | 645 | MG | QD | |||||||
| 103478572 | 10347857 | 16 | C | FOLVITE | FOLIC ACID | 1 | Oral | 400 UG, 1X/DAY | 0 | 400 | UG | TABLET | QD | ||||||
| 103478572 | 10347857 | 17 | C | LACTOBACILLUS RHAMNOSUS | LACTOBACILLUS RHAMNOSUS | 1 | Oral | 1 DF, DAILY | 0 | 1 | DF | CAPSULE | |||||||
| 103478572 | 10347857 | 18 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 8 MG, AS NEEDED (EVERY 8 (EIGHT) HOURS) | 0 | 8 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103478572 | 10347857 | 1 | Fibromyalgia |
| 103478572 | 10347857 | 3 | Muscle spasms |
| 103478572 | 10347857 | 12 | Migraine |
| 103478572 | 10347857 | 18 | Nausea |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103478572 | 10347857 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103478572 | 10347857 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 103478572 | 10347857 | 1 | 2009 | 0 | ||
| 103478572 | 10347857 | 2 | 2012 | 0 |